文献速递乳房整形与再造

建立平衡:在胸肌前植入物乳房重建中使用脱细胞真皮基质能否改善结局?

Establishing an equipoise: Does the use of acellular dermal matrices in pre-pectoral implant-based breast reconstruction improve outcomes?
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-09-17

本研究通过专家共识调查,探讨在胸肌前植入物乳房重建中使用脱细胞真皮基质(ADM)的疗效与证据水平。来自英国、意大利和澳大利亚的32名参与者完成在线调查,结果显示对ADM相关手术结局缺乏共识,56.3%的参与者认为该主题科学证据稀缺。作者结论认为,鉴于临床平衡,需要大规模前瞻性随机对照数据来确定ADM是否能改善结局。

要点

  • 32名国际专家参与调查,对ADM相关手术结局缺乏共识。
  • 仅21.9%参与者认为ADM减少短期并发症和植入物失败/取出风险。
  • 56.3%参与者认为该主题科学证据稀缺,作者结论需大规模前瞻性随机对照数据。

核心结论

  • 研究显示国际外科医生对胸肌前植入物乳房重建中ADM的手术结局、疗效和证据基础缺乏共识。
  • 作者认为鉴于临床平衡,需要大规模前瞻性随机对照数据来确定ADM是否能改善结局。

研究设计与样本

  • 通过专家共识调查(在线问卷调查)进行,由专家指导小组设计,通过国家和国际专业组织宣传。
  • 共32名来自英国、意大利和澳大利亚的参与者完成调查。

主要发现

  • 参与者对ADM相关手术结局存在分歧。
  • 认为ADM减少短期并发症和植入物失败/取出的参与者占少数(21.9%)。
  • 认为ADM改善美容结局的参与者占43.8%,认为减少长期并发症的占40.6%,为相对多数。
  • 56.3%的参与者认为该主题科学证据稀缺。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Breast cancer is the most common malignancy among women in the United Kingdom. Surgical management commonly comprises mastectomy and reconstruction, of which implant-based breast reconstruction (IBBR) is the most prevalent. Acellular dermal matrices (ADM) are widely used in pre-pectoral IBBR; however, there is limited high-quality evidence supporting their efficacy. This study aimed to establish an equipoise via an expert consensus survey. METHODS: An online survey was designed with a steering group of experts. Questions covered participant information, opinions regarding surgical outcomes with ADM use in pre-pectoral IBBR and opinions regarding the available scientific evidence on the topic. The survey was advertised via national and international professional organisations. Quantitative and qualitative analyses were performed. RESULTS: Thirty-two participants from the UK, Italy and Australia completed the survey. Key findings of this study included disagreement among participants regarding the surgical outcomes associated with ADM use. Participants who believed that ADM reduced the risk of short-term complications and implant failure/explantation comprised a minority (21.9%). Participants who felt that ADM use improved cosmetic outcomes and reduced long-term complications were a relative majority at 43.8% and 40.6%, respectively. Furthermore, 56.3% of the participants felt that there was scarce scientific evidence on the topic. CONCLUSIONS: This study provides insights from international surgeons, establishing a lack of consensus on surgical outcomes, efficacy and evidence-base supporting the use of ADMs in pre-pectoral IBBR. Given this clinical equipoise, alongside the growing burden of breast cancer associated morbidity and need for reconstruction, the implications of this study are that large-scale, prospective, randomised-controlled data are needed to establish whether ADM use in pre-pectoral breast reconstruction improves the outcomes.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Cook H, Zargaran D, Glynou SP, et al. Establishing an equipoise: Does the use of acellular dermal matrices in pre-pectoral implant-based breast reconstruction improve outcomes? J Plast Reconstr Aesthet Surg. 2024. PMID: 39340878. doi:10.1016/j.bjps.2024.09.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。